Gambia panel to sanction India firm for cough syrup deaths

A parliamentary committee in The Gambia has recommended prosecution of Indian manufacturer of cough syrups suspected of causing the deaths of at least seventy children in the country.

It said Maiden Pharmaceuticals should be held accountable for exporting what it called contaminated medicine.

WHO had issued an alert in October advising regulators to stop the sale of the syrups.

However, Maiden Pharmaceuticals had denied the allegations as government labs in India said their tests on the syrups found that they were “complying with specifications”.